focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 176.60
Bid: 176.00
Ask: 176.40
Change: 2.00 (1.15%)
Spread: 0.40 (0.227%)
Open: 173.20
High: 176.80
Low: 173.00
Prev. Close: 174.60
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

12 May 2021 07:00

RNS Number : 2936Y
C&C Group Plc
12 May 2021
 

Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached [ii]:

C&C GROUP PLC

2. Reason for the notification (please tick the appropriate box or boxes):

[X] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]:

BlackRock, Inc.

4. Full name of shareholder(s) (if different from 3.)[iv]:

See Section 9

5. Date of the transaction and date on which the threshold is crossed or reached[v]: 10th May 2021

6. Date on which issuer notified: 11th May 2021

7. Threshold(s) that is/are crossed or reached:

Holdings for BLK, Inc. moved above 3%, 4%

 

 

8. Notified details:

 

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii][viii]

Number of Shares[ix]

Number of Voting rights[x]

Number of shares[xi]

Number of voting rights[xii]

% of voting rights

Direct

Direct[xiii]

Indirect[xiv]

Direct

Indirect

IE00B010DT83

N/A

N/A

N/A

N/A

14,829,887

N/A

4.76%

SUBTOTAL A (based on aggregate voting rights)

 

 

 

14,829,887

4.76%

 

B) Financial Instruments

Resulting situation after the triggering transaction[xv]

Type of financial instrument

Expiration Date[xvi]

Exercise/Conversion Period/ Date[xvii]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL B (in relation to all expiration dates)

 

 

 

Total (A+B)

number of voting rights

% of voting rights

14,829,887

14,829,887

4.76%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xviii]:

 

Each of the following entities, which are wholly owned subsidiaries of BlackRock, Inc., hold the following interests in voting rights in their capacity as Investment Manager on behalf of clients:

Investment Manager

Voting Rights

%

BlackRock Investment Management (UK) Limited

6,244,920

2.00%

BlackRock Fund Advisors

3,759,246

1.21%

BlackRock Advisors (UK) Limited

2,642,452

0.85%

BlackRock Institutional Trust Company, National Association

2,063,406

0.66%

BlackRock Asset Management Canada Limited

117,915

0.04%

BlackRock Investment Management (Australia) Limited

1,948

0.00%

 

10. In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date].

11. Additional information:

Done at 12 Throgmorton Avenue, London, EC2N 2DL, U.K. on 11th May 2021.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFITEDILLIL
Date   Source Headline
24th May 202312:00 pmRNSDirector/PDMR Shareholding
24th May 20237:00 amBUSFinal Results
19th May 20237:00 amBUSStatement re Trading Update & Directorate Changes
16th May 20232:00 pmRNSDirector/PDMR Shareholding
4th May 20231:30 pmRNSHolding(s) in Company
17th Apr 20233:45 pmRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amBUSPre-close Trading Statement
16th Mar 20233:15 pmRNSDirector/PDMR Shareholding
15th Mar 20232:00 pmRNSHolding(s) in Company
23rd Feb 202311:00 amRNSHolding(s) in Company
15th Feb 20234:15 pmRNSDirector/PDMR Shareholding
10th Feb 20232:19 pmBUSStatement re Directorate Changes and Board Committee Update
26th Jan 20233:45 pmRNSHolding(s) in Company
17th Jan 20232:40 pmRNSDirector/PDMR Shareholding
13th Jan 20237:00 amBUSTrading Statement
16th Dec 20222:45 pmRNSDirector/PDMR Shareholding
15th Dec 20223:15 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amBUSStatement re Directorate Change and Board Committee Update
5th Dec 20224:30 pmRNSHolding(s) in Company
2nd Dec 20222:28 pmRNSDirector Declaration
30th Nov 20224:45 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSBlock listing Interim Review
21st Nov 202212:00 pmRNSDirector/PDMR Shareholding
18th Nov 20227:10 amRNSDirector Declaration
9th Nov 20229:15 amRNSHolding(s) in Company
14th Sep 20227:00 amBUSStatement re H1 pre-close Trading Statement
16th Aug 20222:15 pmRNSDirector/PDMR Shareholding
28th Jul 202211:00 amRNS2021 Long Term Incentive Plan (‘LTIP’) Awards
26th Jul 20223:15 pmRNSDirector/PDMR Shareholding
20th Jul 202212:00 pmRNSDirector/PDMR Shareholding
18th Jul 20224:00 pmRNSHolding(s) in Company
15th Jul 20225:05 pmRNSDirector/PDMR Shareholding
7th Jul 20222:30 pmRNSResult of AGM
7th Jul 20227:00 amBUSAGM Statement
29th Jun 20223:30 pmRNSHolding(s) in Company
23rd Jun 20225:39 pmRNSHolding(s) in Company
15th Jun 20225:10 pmRNSDirector/PDMR Shareholding
10th Jun 20227:00 amRNSDirector/PDMR Shareholding
8th Jun 20228:30 amRNSAnnual Report and Notice of AGM
31st May 20224:45 pmRNSHolding(s) in Company
31st May 20227:00 amRNSBlock listing Interim Review
30th May 202210:00 amRNSHolding(s) in Company
24th May 20225:45 pmRNSHolding(s) in Company
17th May 20222:00 pmRNSDirector/PDMR Shareholding
17th May 20227:00 amBUSFinal Results
3rd May 20224:15 pmRNSDirector/PDMR Shareholding
16th Mar 20222:30 pmRNSDirector/PDMR Shareholding
16th Mar 20227:00 amBUSTrading Statement
16th Feb 20223:45 pmRNSDirector/PDMR Shareholding
15th Feb 20222:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.